TOP STORIES

• ORGANIZATION New Established Drugs’ Group Places Top Priority on Stable Generic Supply; Research-Driven and Foreign Firms to Join
  August 20, 2021

• BUSINESS Yamasa Ramps Up API CMO Biz for Oligonucleotides, mRNA Drugs amid Changes in Modalities
  August 19, 2021

• BUSINESS Choseido Likely to Face Administrative Penalty over Manufacturing Flaws
  August 18, 2021

• BUSINESS Japan Pharma Market Delivers 1st Growth in 5 Qtrs in April-June: IQVIA
  August 18, 2021

• REGULATORY 14 Firms Flock to Get Approval for E Keppra Generics towards December Listing
  August 17, 2021

• ACADEMIA Evrysdi Debut Expands SMA Treatment Options, Improved Use Expected for All 3 Drugs: Professor
  August 16, 2021

• BUSINESS Probe Panel Urges Ono to Establish Foundation to Handle Scholarship Donations after Bribery Case
  August 16, 2021

• BUSINESS Evrysdi, Aimovig Now Available; Veklury’s Normal Distribution to Start around October
  August 13, 2021

• BUSINESS Morimoto Pharma Aims at Commercial Production of Freeze-Dried Vaccine in FY2022
  August 12, 2021

• BUSINESS Orizuru Therapeutics Boots Up to Take Over iPSC Assets from T-CiRA, Eyes IPO in 2026
  August 11, 2021

• BUSINESS HIF-PH Drugs’ Sluggish Q1 Sales Signal Tepid Uptake as Side Effect Concerns Weigh
  August 10, 2021

• BUSINESS Foreign Drug Makers Scrapping Sales Offices as Sanofi Follows GSK, Novartis, AZ
  August 6, 2021

• REGULATORY Chuikyo Calls for Balanced Price-Setting for “Specific-Use” Drugs, Sakigake Products
  August 5, 2021

• REGULATORY Ofev Faces 10%-Plus Cut in Quarterly Price Review; Veklury Gets Listing but No Copay for Now
  August 5, 2021

• REGULATORY August Listing OK’ed for Evrysdi, Veklury, Verquvo, 2 CGRP Migraine Meds and More
  August 4, 2021

• REGULATORY Veklury to Join NHI Price List to Enter Normal Distribution Channel; Peak Sales Put at 18 Billion Yen
  August 3, 2021

• REGULATORY Lilly’s Selpercatinib Clears Key Panel, in Line for September Approval
  August 2, 2021

• BUSINESS Takeda’s Q1 Sales Rise on Diabetes Divestiture; Plant Re-Inspection Results Expected Late October
  August 2, 2021

• REGULATORY AstraZeneca Vaccine OK’ed for Age 40 and Up under Emergency Program
  August 2, 2021

• ORGANIZATION New Industry Czar Vows to Balance Interests of Innovative Pharma, Gx Businesses as Budget Debate Creates Divide
  July 30, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 83
• 84
• 85
• 86
• 87
• 88
• 89
• 90
• 91
• …
• Next ›
• 最終 »